Also trades as: ELLXF (OTC) · $vol 0M
EXL.AX ASX
Elixinol Wellness Limited
1W: -12.5%
1M: -12.5%
3M: +16.7%
YTD: -30.0%
1Y: -58.8%
A$0.01 ($0.01)
+0.00 (+14.29%)
Weekly Expected Move ±18.9%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$3M
+7.4% ▲
Capital Expenditures
$65K
-8.3% ▼
5Y CAGR: -27.7%
Free Cash Flow
-$3M
+7.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
$327K
-11.6% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$17M | -$11M | -$8M | -$2M | -$6M |
| Depreciation & Amort. | $1M | $721K | $597K | $1M | $869K |
| Stock-Based Comp. | $194K | $241K | $675K | $0 | $0 |
| Change in Working Capital | -$3M | $180K | $2M | $1M | $754K |
| Other Non-Cash Items | $10M | $3M | $2M | -$4M | $663K |
| Operating Cash Flow | -$14M | -$8M | -$3M | -$3M | -$3M |
| — Investing Activities — | |||||
| Capital Expenditures | -$292K | -$12K | -$12K | -$60K | -$101K |
| Acquisitions (Net) | $464K | $291K | $192K | -$2M | -$117K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | -$1M | -$1M | $2M | $2K |
| Investing Cash Flow | $172K | -$869K | -$1M | -$66K | -$216K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1M | -$757K | $300K | $861K | $2M |
| Stock Repurchased | -$110K | $0 | $0 | -$564K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$738K | -$1M | -$305K |
| Financing Cash Flow | -$1M | -$757K | $2M | $4M | $4M |
| Net Change in Cash | -$15M | -$10M | -$2M | $370K | $327K |
| Cash End of Period | $13M | $3M | $708K | $1M | $1M |
| Free Cash Flow | -$14M | -$8M | -$3M | -$4M | -$3M |